Skin Diseases, Metabolic
Skin Diseases, Metabolic
Explore linked clinical trials. Standard reference: MESH:M001993620 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Meal Macronutrients on Postprandial Lipids | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Insulin Resistance, Lipid Metabolism Disorders, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, Urogenital Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, kidney disorder, lipodystrophy, metabolic disease, nephrosis, nephrotic syndrome, skin disorder, urinary system disorder | Not yet recruiting | Phase 2 | 2026-10-09 | NCT07313787 | |
| Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperlipidemia, hypertriglyceridemia, lipodystrophy, metabolic disease, skin disorder | Active, not recruiting | Phase 2 | 2026-10-08 | NCT02262806 | |
| Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperlipidemia, hypertriglyceridemia, lipodystrophy, metabolic disease, skin disorder | Active, not recruiting | Phase 3 | 2026-09-22 | NCT02262832 | |
| Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, congenital generalized lipodystrophy, familial partial lipodystrophy, hereditary disease, inborn errors of metabolism, laminopathy, lipodystrophy, metabolic disease, skin disorder | Recruiting | Phase 3 | 2026-09-11 | NCT07220785 | |
| Sexual Quality of Life in Female Patients With Lipodystrophy Syndromes or Turner's Syndrome: a Case-control Study | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Sex Chromosome Disorders, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, Turner syndrome, Urogenital Abnormalities, Urogenital Diseases, cardiovascular disorder, chromosomal disorder, congenital heart disease, disorder of sexual differentiation, endocrine system disorder, familial partial lipodystrophy, gonadal disorder, gonadal dysgenesis, heart disorder, hereditary disease, laminopathy, lipodystrophy, metabolic disease, sex chromosome disorder of sex development, skin disorder | Not yet recruiting | Not stated | 2026-09-02 | NCT07799012 | |
| Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD) | Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, lipodystrophy, metabolic disease, skin disorder | Recruiting | Not stated | 2026-08-18 | NCT05996536 | |
| Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy | Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, lipodystrophy, metabolic disease, skin disorder | Recruiting | Not stated | 2026-08-18 | NCT05419037 | |
| Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With "Classic" Polycystic Ovary Syndrome (PCOS) | Adnexal Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cysts, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, Urogenital Diseases, endocrine system disorder, familial partial lipodystrophy, female reproductive system disorder, gonadal disorder, hereditary disease, laminopathy, lipodystrophy, metabolic disease, neoplasm, ovarian cyst, ovarian disorder, polycystic ovary syndrome, skin disorder | Recruiting | Not applicable | 2026-08-10 | NCT07412028 | |
| Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, familial partial lipodystrophy, hereditary disease, laminopathy, lipodystrophy, metabolic disease, skin disorder | Recruiting | Phase 3 | 2026-07-16 | NCT06679270 | |
| MEASuRE: Metreleptin Effectiveness And Safety Registry | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, acquired partial lipodystrophy, congenital generalized lipodystrophy, hereditary disease, inborn errors of metabolism, lipodystrophy, metabolic disease, partial lipodystrophy, skin disorder | Recruiting | Not stated | 2026-07-16 | NCT02325674 | |
| The LD Lync Study - Natural History Study of Lipodystrophy Syndromes | Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, lipodystrophy, metabolic disease, skin disorder | Recruiting | Not stated | 2026-03-19 | NCT03087253 | |
| 64Cu-GRIP B in Patients With Advanced Malignancies | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Male Urogenital Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, congenital generalized lipodystrophy, hereditary disease, inborn errors of metabolism, kidney cancer, kidney disorder, lipodystrophy, male reproductive organ cancer, male reproductive system disorder, metabolic disease, neoplasm, prostate cancer, prostate disorder, skin disorder, urethra neoplasm, urethral disorder, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2026-03-17 | NCT05888532 | |
| Registry for Patients With Lipodystrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, familial partial lipodystrophy, hereditary disease, laminopathy, lipodystrophy, metabolic disease, skin disorder | Recruiting | Not stated | 2025-12-02 | NCT03553420 | |
| The Skin Barrier in Users of Diabetes Devices | Inflammation, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Eczematous, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, atopic eczema, autoimmune disease, dermatitis, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, lipodystrophy, metabolic disease, skin disorder, type 1 diabetes mellitus | Recruiting | Not stated | 2025-09-09 | NCT06856954 | |
| Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE" | Body Weight, Infections, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, lipodystrophy, metabolic disease, nutritional disorder, obesity disorder, overnutrition, skin disorder | Recruiting | Not applicable | 2025-08-12 | NCT06236932 | |
| Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, congenital generalized lipodystrophy, hereditary disease, inborn errors of metabolism, lipodystrophy, metabolic disease, skin disorder | Not yet recruiting | Not stated | 2025-04-08 | NCT06916442 | |
| The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lymphoma, Extranodal NK-T-Cell, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, T-cell non-Hodgkin lymphoma, congenital generalized lipodystrophy, hereditary disease, inborn errors of metabolism, lipodystrophy, lymphoma, metabolic disease, neoplasm, skin disorder | Not yet recruiting | Not stated | 2025-03-07 | NCT06863441 | |
| PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma | B-cell neoplasm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, congenital generalized lipodystrophy, diffuse large B-cell lymphoma, hereditary disease, immune system disorder, immunoproliferative disorder, inborn errors of metabolism, lipodystrophy, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, metabolic disease, neoplasm, skin disorder | Recruiting | Not stated | 2025-01-01 | NCT06755775 | |
| GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Neoplasms by Site, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, congenital generalized lipodystrophy, hereditary disease, inborn errors of metabolism, lipodystrophy, metabolic disease, neoplasm, skin disorder | Recruiting | Not stated | 2024-12-10 | NCT06725940 | |
| Low Energy Diet and Familial Partial Lipodystrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, diabetes mellitus, endocrine system disorder, familial partial lipodystrophy, glucose metabolism disease, hereditary disease, laminopathy, lipodystrophy, metabolic disease, skin disorder | Recruiting | Not applicable | 2024-12-05 | NCT03900286 |